Birrer, M. J. | Search bioRxiv

bioRxiv2020

DAGBagM: Learning directed acyclic graphs of mixed variables with an application to identify prognostic protein biomarkers in ovarian cancer

MotivationDirected gene/protein regulatory networks inferred by applying directed acyclic graph (DAG) models to proteogenomic data has been shown effective for detecting causal biomarkers of clinical outcomes. However, there remain unsolved challenges in DAG learning to jointly model clinical outcome variables, which often take binary values, and biomarker measurements, which usually are continuous variables. Therefore, in this paper, we propose a new tool, DAGBagM, to learn DAGs with both continuous and binary nodes. By using appropriate models for continuous and binary variables, DAGBagM allows for either type of nodes to be parents or children nodes in the learned graph. DAGBagM also employs a bootstrap aggregating strategy to reduce false positives and achieve better estimation accuracy. Moreover, the aggregation procedure provides a flexible framework to robustly incorporate prior information on edges for DAG reconstruction. ResultsAs shown by simulation studies, DAGBagM performs better in identifying edges between continuous and binary nodes, as compared to commonly used strategies of either treating binary variables as continuous or discretizing continuous variables. Moreover, DAGBagM outperforms several popular DAG structure learning algorithms including the score-based hill climbing (HC) algorithm, constraint-based PC-algorithm (PC-alg), and the hybrid method max-min hill climbing (MMHC) even for constructing DAG with only continuous nodes. The HC implementation in the R package DAGBagM is much faster than that in a widely used DAG learning R package bnlearn. When applying DAGBagM to proteomics datasets from ovarian cancer studies, we identify potential prognostic protein biomarkers in ovarian cancer. Availability and implementationDAGBagM is made available as a github repository https://github.com/jie108/dagbagM.

systems biology↗

bioRxiv2018

The impact of stroma on the discovery of molecular subtypes and prognostic gene signatures in serous ovarian cancer

PurposeRecent efforts to improve outcomes for high-grade serous ovarian cancer, a leading cause of cancer death in women, have focused on identifying molecular subtypes and prognostic gene signatures, but existing subtypes have poor cross-study robustness. We tested the contribution of cell admixture in published ovarian cancer molecular subtypes and prognostic gene signatures.\n\nExperimental DesignPublic gene expression data, two molecular subtype classifications, and 61 published gene signatures of ovarian cancer were examined. Using microdissected data, we developed gene signatures of ovarian tumor and stroma. Computational simulations of increasing stromal cell proportion were performed by mixing gene expression profiles of paired microdissected ovarian tumor and stroma.\n\nResultsEstablished ovarian cancer molecular subtypes are strongly associated with the cell admixture. Tumors were classified as different molecular subtypes in simulations, when the percentage of stromal cells increased. Stromal gene expression in bulk tumor was weakly prognostic, and in one dataset, increased stroma was associated with anatomic sampling location. Five published prognostic gene signatures were no longer prognostic in a multivariate model that adjusted for stromal content alone.\n\nConclusionsThe discovery that molecular subtypes of high grade serous ovarian cancer is influenced by cell admixture, and stromal cell gene expression is crucial for interpretation and reproduction of ovarian cancer molecular subtypes and gene signatures derived from bulk tissue. Single cell analysis may be required to refine the molecular subtypes of high grade serous ovarian cancer. Because stroma proportion was weakly prognostic, elucidating the role of the tumor microenvironments components will be important.\n\nTranslational relevanceOvarian cancer is a leading cause of cancer death in women in the United States. Although the tumor responds to standard therapy for the majority of patients, it frequently recurs and becomes drug-resistant. Recent efforts have focused on identifying molecular subtypes and prognostic gene signatures of ovarian cancer in order to tailor therapy and improve outcomes. This study demonstrates that molecular subtype identification depends on the ratio of tumor to stroma within the specimen. We show that the specific anatomic location of the biopsy may influence the proportion of stromal involvement and potentially the resulting gene expression pattern. It will be crucial for these factors to be taken into consideration when interpreting and reproducing ovarian cancer molecular subtypes and gene signatures derived using bulk tissue and single cells. Furthermore, it will be important to define the relative proportions of stromal cells and model their prognostic importance in the tumor microenvironment.

bioinformatics↗